Characterization of immune checkpoint inhibitor‐induced cardiotoxicity reveals interleukin‐17A as a driver of cardiac dysfunction after anti‐PD‐1 treatment

Tamás G. Gergely(Semmelweis University), Zoltán V. Varga(Semmelweis University)
British Journal of Pharmacology
November 10, 2022
Cited by 60


Related Papers